Immuno-Chemistry Slides & Blocks Test at Chughtai Lab

Immuno-Chemistry (Slides / Blocks) at Chughtai Lab

Immuno-Chemistry, widely known in clinical pathology as Immunohistochemistry (IHC), is an advanced diagnostic technique performed on tissue specimens. This highly specialized analysis is conducted on tissue sections mounted on glass slides or embedded in paraffin wax blocks. The procedure plays a pivotal role in modern medicine, particularly in oncology, pathology, and personalized therapeutics. By exploiting the highly specific binding affinity between antibodies and target antigens, immunohistochemistry allows pathologists to visualize the precise localization, distribution, and abundance of specific proteins within cellular structures under a light microscope.

The fundamental technology behind Immuno-Chemistry involves utilizing labeled antibodies as molecular probes. When a tissue sample is submitted to Chughtai Lab, it undergoes a series of biochemical reactions. If the specific protein or antigen of interest is present in the tissue, the primary antibody binds to it. A secondary detection system, which typically contains an enzyme-conjugated antibody, is then introduced to bind to the primary antibody. Upon the addition of a chromogenic substrate, such as diaminobenzidine (DAB), a visible, colored precipitate (usually brown or red) forms at the site of the antigen-antibody complex. This color change is then evaluated by a consultant pathologist to determine cellular characteristics that are invisible during routine microscopic examinations.

The clinical importance of Immuno-Chemistry cannot be overstated. While standard Hematoxylin and Eosin (H&E) staining provides essential morphological details about tissue architecture, it often cannot differentiate between tumors that look identical but behave differently. Immuno-Chemistry provides a molecular-level evaluation that is crucial for accurate tumor subtyping, identifying the primary origin of metastatic cancers, determining prognostic indicators, and selecting patients for targeted therapies. This diagnostic value directly influences patient management, helping oncologists design highly tailored treatment protocols that improve survival rates and minimize unnecessary side effects.

Clinical Procedure: What to Expect

Patient Preparation

Because Immuno-Chemistry is a laboratory analysis performed on pre-existing tissue samples (paraffin blocks or unstained slides) obtained from a previous biopsy or surgical resection, there is no direct physical preparation required for the patient. However, ensuring the integrity of the specimen and clinical history is vital for an accurate analysis. Patients should observe the following guidelines:

• Retrieve Original Specimens: Patients must obtain the paraffin-embedded tissue blocks (often called “paraffin blocks”) and the corresponding glass slides from the initial pathology laboratory where the biopsy or surgery was performed.
• Provide Clinical Documentation: It is mandatory to submit the original histopathology report along with the slides and blocks. The pathologist at Chughtai Lab requires this clinical history to select the most appropriate panel of immunohistochemical markers.
• Ensure Safe Transport: Tissue blocks and slides must be transported in a secure, temperature-controlled container. Avoid exposing the paraffin blocks to extreme heat, direct sunlight, or moisture, as high temperatures can melt the wax and damage the tissue proteins.
• Verify Physician Orders: Ensure you have a clear prescription or referral letter from your treating oncologist or surgeon specifying the clinical suspicion or the exact IHC markers requested.

During the Procedure

The actual procedure of Immuno-Chemistry takes place entirely within the histopathology laboratory of Chughtai Lab. The process involves several highly controlled technical steps:

• Specimen Logging and Verification: Upon submission, the slides and blocks are registered in the laboratory information system, ensuring strict patient identification and sample tracking.
• Microtomy (Sectioning): If a paraffin block is submitted, a skilled histotechnologist uses a high-precision instrument called a microtome to cut ultra-thin sections of the tissue, measuring approximately 3 to 5 microns in thickness. These sections are carefully floated on a water bath and mounted onto specialized, positively charged glass slides to prevent tissue detachment during subsequent staining steps.
• Deparaffinization and Rehydration: The mounted tissue slides are heated and treated with solvents like xylene to remove the paraffin wax, followed by gradual rehydration through graded alcohols to water.
• Antigen Retrieval: The process of tissue fixation in formalin often masks the target proteins. To expose these hidden proteins (epitopes), the slides undergo antigen retrieval using heat-induced epitope retrieval (HIER) or enzymatic digestion.
• Antibody Incubation: The slides are incubated with highly specific primary antibodies, followed by secondary antibodies linked to detection enzymes.
• Chromogen Development and Counterstaining: A chromogenic substrate is applied to produce a visible color reaction. The slides are then counterstained (usually with hematoxylin) to visualize cell nuclei, dehydrated, and sealed with a coverslip.
• Pathologist Evaluation: A consultant pathologist reviews the slides under a high-power light microscope, assessing the percentage of stained cells, intensity of staining, and cellular localization (nuclear, cytoplasmic, or membranous).

When is an Immuno-Chemistry (Slides / Blocks) Performed?

Classification of Undifferentiated Tumors

Physicians frequently request Immuno-Chemistry when a routine biopsy specimen reveals a highly abnormal, poorly differentiated tumor. In such cases, standard microscopic examination cannot determine whether the tumor is a carcinoma (originating from epithelial cells), lymphoma (originating from immune cells), melanoma (originating from pigment cells), or sarcoma (originating from connective tissue). By applying a lineage-specific panel of IHC markers, pathologists can definitively classify the tumor, which is the critical first step in determining the appropriate therapeutic approach.

Identification of the Primary Site in Metastatic Cancer

When a patient presents with metastatic cancer—where the disease has spread to organs like the liver, lungs, bones, or brain—the primary source of the cancer is often unknown. This clinical scenario is referred to as Cancer of Unknown Primary (CUP). Oncologists request Immuno-Chemistry on the metastatic tissue biopsy to identify the organ of origin. Specific organ-associated markers help pathologists determine if the tumor originated in the lung, colon, breast, prostate, or thyroid, allowing for targeted, organ-specific cancer treatment.

Determination of Prognostic and Predictive Markers in Breast Cancer

In breast cancer management, Immuno-Chemistry is standard practice for every newly diagnosed case. Pathologists evaluate the expression of Estrogen Receptors (ER), Progesterone Receptors (PR), and Human Epidermal Growth Factor Receptor 2 (HER2). The presence or absence of these receptors determines the tumor’s biological behavior (prognosis) and directly predicts whether the patient will respond to hormone therapies (like tamoxifen) or targeted monoclonal antibody therapies (like trastuzumab).

Subtyping of Hematolymphoid Malignancies

Diagnosing lymphomas and leukemias requires highly precise classification, as there are dozens of distinct subtypes that require vastly different treatment regimens. Physicians order Immuno-Chemistry on lymph node biopsies or bone marrow trephine blocks to identify specific cluster of differentiation (CD) markers. This detailed immunophenotyping distinguishes between B-cell and T-cell malignancies, Hodgkin and non-Hodgkin lymphomas, and specific subtypes, ensuring the patient receives the correct chemotherapy protocol.

Assessment of Tumor Proliferation and Aggressiveness

Oncologists often need to understand how rapidly a tumor is growing to assess its aggressiveness and potential response to chemotherapy. Immuno-Chemistry using the Ki-67 marker is performed to measure the cellular proliferation index. A high Ki-67 percentage indicates a rapidly dividing tumor, which may require more aggressive systemic treatment, whereas a low Ki-67 index suggests a slower-growing, more indolent disease process.

What Does an Immuno-Chemistry (Slides / Blocks) Detect?

Immuno-Chemistry is designed to detect a wide array of specific cellular proteins, receptors, and molecular targets. Depending on the clinical indication, the test can detect:

• Estrogen Receptor (ER): Nuclear expression in breast and endometrial tissues, guiding endocrine therapy.
• Progesterone Receptor (PR): Nuclear marker used in conjunction with ER for breast cancer characterization.
• HER2/neu: Membranous protein overexpression in breast and gastric cancers, indicating eligibility for anti-HER2 therapy.
• Ki-67: A nuclear protein strictly associated with cellular proliferation, indicating the growth fraction of a tumor.
• Cytokeratin 7 (CK7): An intermediate filament protein expressed in glandular epithelial cells of the lung, breast, and upper gastrointestinal tract.
• Cytokeratin 20 (CK20): An epithelial marker primarily positive in colorectal adenocarcinomas and Merkel cell carcinomas.
• Thyroid Transcription Factor-1 (TTF-1): A nuclear marker highly specific for primary lung adenocarcinomas and thyroid cancers.
• CD20: A cell surface marker expressed on mature B-lymphocytes, crucial for diagnosing B-cell lymphomas.
• CD3: A T-cell co-receptor marker used to identify T-lymphocytes and T-cell malignancies.
• Prostate-Specific Antigen (PSA): Cytoplasmic expression in prostatic epithelial cells, used to confirm metastatic prostate cancer.
• S100 Protein: A soluble acidic protein highly sensitive for cells of neural crest origin, including melanomas and schwannomas.
• Melan-A / HMB-45: Specific cytoplasmic markers used to confirm the diagnosis of malignant melanoma.
• Synaptophysin: A membrane glycoprotein of synaptic vesicles, indicating neuroendocrine differentiation.
• Chromogranin A: An acid soluble protein found in secretory granules of neuroendocrine cells.
• CD117 (c-KIT): A receptor tyrosine kinase highly positive in Gastrointestinal Stromal Tumors (GIST).
• Calretinin: A calcium-binding protein used as a primary marker to identify mesothelioma and differentiate it from adenocarcinoma.
• Vimentin: An intermediate filament protein characteristic of mesenchymal cells, positive in most sarcomas.
• CD30 & CD15: Markers co-expressed on Reed-Sternberg cells, diagnostic for classical Hodgkin lymphoma.
• p53: A tumor suppressor protein; abnormal accumulation or complete absence indicates TP53 gene mutation.
• E-cadherin: A cell adhesion molecule whose loss of expression is characteristic of lobular breast carcinoma.
• GATA3: A transcription factor highly expressed in breast and urothelial carcinomas.
• PAX8: A nuclear transcription factor expressed in renal, thyroid, and Müllerian tumors.
• Desmin: An intermediate filament protein specific to smooth and skeletal muscle differentiation.
• Mismatch Repair (MMR) Proteins (MLH1, MSH2, MSH6, PMS2): Evaluated to detect Lynch syndrome and microsatellite instability (MSI) in colorectal and endometrial cancers.
• p40 / p63: Nuclear markers highly specific for squamous cell differentiation, helping to distinguish squamous cell carcinoma from adenocarcinoma.

Turnaround Time and Report Access at Chughtai Lab

Immuno-Chemistry is a highly complex, multi-step diagnostic process that requires meticulous laboratory preparation, precise staining, and detailed microscopic analysis by expert pathologists. Due to the intricate nature of the testing, which often involves running multiple antibody panels and control slides, the turnaround time for Immuno-Chemistry (Slides / Blocks) at Chughtai Lab typically ranges from 3 to 5 working days. This timeline ensures that every sample undergoes rigorous quality control checks and clinical correlation before a final report is issued.

Chughtai Lab offers seamless and convenient access to diagnostic reports. Once the consultant pathologist signs off on the final analysis, patients are immediately notified via an SMS alert. The complete, detailed report can be accessed and downloaded online through the official Chughtai Lab website by entering the patient’s case ID and password. Additionally, patients can download the Chughtai Active Mobile App to view, save, and share their reports directly with their treating oncologists. For those who prefer physical copies, printed reports can be collected from any Chughtai Lab collection center across Pakistan.

Immuno-Chemistry (Slides / Blocks) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Breast Tissue (ER/PR Receptors)	Physiological nuclear expression in normal breast lobules and ducts.	Strong, diffuse nuclear positivity in tumor cells (indicates hormone-receptor-positive breast cancer).
Lymph Node (CD20/CD3 Distribution)	Balanced, organized distribution of B-cells (CD20+) in follicles and T-cells (CD3+) in paracortical areas.	Monoclonal expansion of CD20+ or CD3+ cells, disrupting normal lymph node architecture (indicates lymphoma).
Lung Mass (TTF-1 / p40 Expression)	Normal alveolar epithelial expression of TTF-1; no p40 expression in glandular tissue.	Diffuse TTF-1 positivity (indicates adenocarcinoma) or diffuse p40 positivity (indicates squamous cell carcinoma).
Metastatic Tumor (CK7 / CK20 Profile)	Organ-specific normal epithelial expression.	CK20 positive and CK7 negative profile (highly suggestive of metastatic colorectal adenocarcinoma).
Gastrointestinal Mass (CD117 / c-KIT)	Negative in normal smooth muscle and epithelial cells.	Strong, diffuse cytoplasmic and membranous positivity (diagnostic for Gastrointestinal Stromal Tumor – GIST).
Suspected Skin Lesion (S100 / Melan-A)	Confined to normal epidermal melanocytes.	Diffuse, strong positivity in atypical melanocytic nests invading the dermis (confirms malignant melanoma).
Neuroendocrine Markers (Synaptophysin)	Negative in non-neuroendocrine tissues.	Strong cytoplasmic positivity in tumor cells (indicates neuroendocrine tumor or small cell carcinoma).
Tumor Proliferation Index (Ki-67)	Low physiological cellular proliferation (typically less than 5% in normal resting tissues).	Elevated proliferation index (ranging from 20% to over 90%, indicating highly aggressive, rapidly dividing cancer).

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Immuno-Chemistry (Slides / Blocks)?

• Expert Consultant Pathologists: Chughtai Lab features a dedicated team of highly qualified, fellowship-trained histopathologists with extensive subspecialty expertise in oncological pathology and immunohistochemical interpretation.
• Fully Automated Staining Systems: The laboratory utilizes state-of-the-art, fully automated immunohistochemistry staining platforms that minimize manual errors and ensure highly reproducible, standardized results.
• Vast Antibody Menu: Chughtai Lab maintains an extensive library of primary antibodies, allowing for the evaluation of rare, complex, and highly specific tumor markers.
• Strict Quality Assurance: The laboratory adheres to rigorous international quality control standards and regularly participates in external proficiency testing programs, including the College of American Pathologists (CAP).
• Comprehensive Clinical Correlation: Pathologists at Chughtai Lab carefully correlate IHC findings with the patient’s clinical history, radiological findings, and initial H&E slides for maximum diagnostic accuracy.
• Convenient Digital Access: Patients can easily download their detailed pathology reports online via the Chughtai Lab portal or the user-friendly Chughtai Active Mobile App.
• Nationwide Network: With a vast network of collection centers across major cities in Pakistan, including Lahore, Karachi, and Islamabad, patients can easily submit their slides and blocks for testing.
• Patient-Focused Care: Chughtai Lab is committed to providing compassionate, professional, and timely diagnostic services, understanding the critical importance of rapid pathology results in cancer care.